Ruth Eichner

1.3k total citations
9 papers, 551 citations indexed

About

Ruth Eichner is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ruth Eichner has authored 9 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Ruth Eichner's work include Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ruth Eichner is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ruth Eichner collaborates with scholars based in Germany, Austria and United States. Ruth Eichner's co-authors include Florian Bassermann, Michele Pagano, Arno Müllbacher, Paul Waring, Giulio Superti‐Furga, Enrico Girardi, Vanesa Fernández‐Sáiz, Bianca‐Sabrina Targosz, Mari Hashimoto and Marie-Pierre Puisségur and has published in prestigious journals such as Blood, Nature Cell Biology and Cell Host & Microbe.

In The Last Decade

Ruth Eichner

9 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Eichner Germany 8 382 123 72 67 67 9 551
Tony Morales United States 18 638 1.7× 126 1.0× 61 0.8× 148 2.2× 29 0.4× 30 989
S. Yoshida Japan 17 487 1.3× 137 1.1× 64 0.9× 78 1.2× 48 0.7× 39 749
Haiying He China 13 519 1.4× 129 1.0× 150 2.1× 67 1.0× 39 0.6× 30 731
Laurie K. Jackson United States 17 745 2.0× 71 0.6× 70 1.0× 53 0.8× 24 0.4× 23 981
Wei‐Chun HuangFu Taiwan 18 459 1.2× 173 1.4× 82 1.1× 85 1.3× 76 1.1× 43 847
James A. Dowdle United States 6 439 1.1× 86 0.7× 70 1.0× 49 0.7× 44 0.7× 7 606
Jianli Sang China 14 361 0.9× 83 0.7× 61 0.8× 89 1.3× 88 1.3× 37 554
Tim-Michael Decker Germany 10 994 2.6× 114 0.9× 48 0.7× 83 1.2× 66 1.0× 12 1.3k
Vladimir Yong‐Gonzalez United States 8 750 2.0× 125 1.0× 103 1.4× 50 0.7× 20 0.3× 9 846
Mau-Sun Chang Taiwan 20 529 1.4× 128 1.0× 140 1.9× 61 0.9× 88 1.3× 41 864

Countries citing papers authored by Ruth Eichner

Since Specialization
Citations

This map shows the geographic impact of Ruth Eichner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Eichner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Eichner more than expected).

Fields of papers citing papers by Ruth Eichner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Eichner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Eichner. The network helps show where Ruth Eichner may publish in the future.

Co-authorship network of co-authors of Ruth Eichner

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Eichner. A scholar is included among the top collaborators of Ruth Eichner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Eichner. Ruth Eichner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Seckinger, Anja, Michael Heider, Martina Rudelius, et al.. (2021). MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma. Blood Advances. 6(2). 515–520. 7 indexed citations
2.
Seckinger, Anja, Michael Heider, Ruth Eichner, et al.. (2019). MCT1 As Molecularly Validated Predictive Marker for Lenalidomide-Maintenance Therapy in Multiple Myeloma. Blood. 134(Supplement_1). 3187–3187. 1 indexed citations
3.
Sedlyarov, Vitaly, Ruth Eichner, Enrico Girardi, et al.. (2018). The Bicarbonate Transporter SLC4A7 Plays a Key Role in Macrophage Phagosome Acidification. Cell Host & Microbe. 23(6). 766–774.e5. 62 indexed citations
4.
Eichner, Ruth, Vanesa Fernández‐Sáiz, Bianca‐Sabrina Targosz, & Florian Bassermann. (2018). Cross Talk Networks of Mammalian Target of Rapamycin Signaling With the Ubiquitin Proteasome System and Their Clinical Implications in Multiple Myeloma. International review of cell and molecular biology. 343. 219–297. 20 indexed citations
5.
Hashimoto, Mari, Enrico Girardi, Ruth Eichner, & Giulio Superti‐Furga. (2018). Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay. ACS Chemical Biology. 13(6). 1480–1486. 34 indexed citations
6.
Bassermann, Florian, Ruth Eichner, & Michele Pagano. (2013). The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(1). 150–162. 197 indexed citations
7.
Puisségur, Marie-Pierre, Ruth Eichner, Cathy Quelen, et al.. (2012). B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells. Leukemia. 26(10). 2224–2232. 47 indexed citations
8.
Fernández‐Sáiz, Vanesa, Bianca‐Sabrina Targosz, Simone Lemeer, et al.. (2012). SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma. Nature Cell Biology. 15(1). 72–81. 75 indexed citations
9.
Müllbacher, Arno, Paul Waring, & Ruth Eichner. (1985). Identification of an Agent in Cultures of Aspergillus fumigatus Displaying Anti-phagocytic and Immunomodulating Activity in vitro. Microbiology. 131(5). 1251–1258. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026